Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Genomic instability in chronic myeloid leukemia: targets for therapy?

Muvarak N, Nagaria P, Rassool FV.

Curr Hematol Malig Rep. 2012 Jun;7(2):94-102. doi: 10.1007/s11899-012-0119-0.

PMID:
22427031
2.

Genetic mechanisms of chronic myeloid leukemia blastic transformation.

Skorski T.

Curr Hematol Malig Rep. 2012 Jun;7(2):87-93. doi: 10.1007/s11899-012-0114-5. Review.

PMID:
22328017
3.

Genetic events other than BCR-ABL1.

Neviani P.

Curr Hematol Malig Rep. 2014 Mar;9(1):24-32. doi: 10.1007/s11899-013-0194-x. Review.

PMID:
24407376
4.

Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.

Sallmyr A, Fan J, Rassool FV.

Cancer Lett. 2008 Oct 18;270(1):1-9. doi: 10.1016/j.canlet.2008.03.036. Epub 2008 May 7. Review.

PMID:
18467025
5.

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.

Warmuth M, Danhauser-Riedl S, Hallek M.

Ann Hematol. 1999 Feb;78(2):49-64. Review.

PMID:
10089019
6.

MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib.

Albajar M, Gómez-Casares MT, Llorca J, Mauleon I, Vaqué JP, Acosta JC, Bermúdez A, Donato N, Delgado MD, León J.

Mol Cancer Res. 2011 May;9(5):564-76. doi: 10.1158/1541-7786.MCR-10-0356. Epub 2011 Apr 1.

7.

Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia.

Ohyashiki K, Iwama H, Tauchi T, Shimamoto T, Hayashi S, Ando K, Kawakubo K, Ohyashiki JH.

Leuk Lymphoma. 2000 Dec;40(1-2):49-56. Review.

PMID:
11426628
8.

Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.

Melo JV, Deininger MW.

Hematol Oncol Clin North Am. 2004 Jun;18(3):545-68, vii-viii. Review.

PMID:
15271392
10.

BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP.

Salles D, Mencalha AL, Ireno IC, Wiesmüller L, Abdelhay E.

Carcinogenesis. 2011 Jan;32(1):27-34. doi: 10.1093/carcin/bgq216. Epub 2010 Oct 25.

11.

Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

Rumpold H, Webersinke G.

Curr Cancer Drug Targets. 2011 Jan;11(1):3-19. Review.

PMID:
21062244
12.

Chronic myeloid leukemia stem cells.

Jamieson CH.

Hematology Am Soc Hematol Educ Program. 2008:436-42. doi: 10.1182/asheducation-2008.1.436. Review.

PMID:
19074122
13.

Genomic instability: The cause and effect of BCR/ABL tyrosine kinase.

Skorski T.

Curr Hematol Malig Rep. 2007 May;2(2):69-74. doi: 10.1007/s11899-007-0010-6. Review.

PMID:
20425353
14.

p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.

Guinn BA, Mills KI.

Leuk Lymphoma. 1997 Jul;26(3-4):211-26. Review.

PMID:
9322884
15.

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.

Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, Cramer K, Reddy MM, Koptyra M, Penserga T, Glodkowska-Mrowka E, Bolton E, Holyoake TL, Eaves CJ, Cerny-Reiterer S, Valent P, Hochhaus A, Hughes TP, van der Kuip H, Sattler M, Wiktor-Jedrzejczak W, Richardson C, Dorrance A, Stoklosa T, Williams DA, Skorski T.

Blood. 2012 May 3;119(18):4253-63. doi: 10.1182/blood-2011-10-385658. Epub 2012 Mar 12.

16.

Molecular mechanisms of transformation by the BCR-ABL oncogene.

Sattler M, Griffin JD.

Semin Hematol. 2003 Apr;40(2 Suppl 2):4-10. Review.

PMID:
12783368
17.

The cytogenetic scenario of chronic myeloid leukemia.

Mitelman F.

Leuk Lymphoma. 1993;11 Suppl 1:11-5. Review.

PMID:
8251885
18.

Chronic myeloid leukaemia as a model of disease evolution in human cancer.

Melo JV, Barnes DJ.

Nat Rev Cancer. 2007 Jun;7(6):441-53. Review.

PMID:
17522713
20.

Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.

Su XY, Wong N, Cao Q, Yu LZ, Niu C, Wickham N, Johnson PJ, Chen Z, Chen SJ.

Cancer Genet Cytogenet. 1999 Jan 1;108(1):6-12.

PMID:
9973917
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk